Oric Pharmaceuticals ORIC
NASDAQ ORIC
$13.37 +0.10 (+0.75%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oric Pharmaceuticals (ORIC) Common Equity (2019 - 2026)

Updated

Oric Pharmaceuticals (ORIC) posted Common Equity of $381.26 million for Q2 2026, up 17.7% from $324 million a year earlier but down 8.3% from the prior quarter.

Analysis

Oric Pharmaceuticals (ORIC) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Oric Pharmaceuticals' Common Equity came in at $384.36 million, up 58.1% from FY2024.

  • Annual Common Equity has increased for three consecutive years, with a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
  • In prior years, Oric Pharmaceuticals' Common Equity was $243.12 million in FY2024 (+8.5%), $224.09 million in FY2023 (+0.8%), $222.35 million in FY2022 (-18.5%) and $272.98 million in FY2021 (-5.8%).
  • Quarterly Common Equity has run from a low of $202.81 million in Q1 2023 to a high of $415.56 million in Q1 2026 over five years.
  • On a year-over-year basis, Common Equity has increased in each of the last five quarters, with growth averaging 25.8% over the last eight quarters.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q1 2026, with growth of 89.1%; the weakest was Q1 2025, with a decline of 33.1%.
  • According to Business Quant data, Common Equity for the three prior quarters was $415.56 million (Q1 2026), $384.36 million (Q4 2025) and $406.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Oric Pharmaceuticals 1.38 Bn 1.38 Bn - 381.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 381.26 Mn
Mar 31, 2026 415.56 Mn
Dec 31, 2025 384.36 Mn
Sep 30, 2025 406.92 Mn
Jun 30, 2025 324.00 Mn
Mar 31, 2025 219.74 Mn
Dec 31, 2024 243.12 Mn
Sep 30, 2024 273.99 Mn
Jun 30, 2024 302.40 Mn
Mar 31, 2024 328.65 Mn
Dec 31, 2023 224.09 Mn
Sep 30, 2023 247.41 Mn
Jun 30, 2023 268.80 Mn
Mar 31, 2023 202.81 Mn
Dec 31, 2022 222.35 Mn
Sep 30, 2022 214.82 Mn
Jun 30, 2022 236.87 Mn
Mar 31, 2022 253.08 Mn
Dec 31, 2021 272.98 Mn
Sep 30, 2021 291.54 Mn
API Access

Oric Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ORIC&period=max&api_key=YOUR_API_KEY